Abstract
Inflammatory breast cancer (IBC) is a rare and aggressive subtype of breast cancer, and its diagnosis is primarily clinical. IBC follows an aggressive biological course that is typically associated with rapid onset of symptoms and signs, and it is associated with poor overall outcome. Diagnosis of IBC is based on a combination of information derived from medical history, physical examination, and biopsy-confirmed presence of invasive cancer. Patients with IBC typically present with a history of less than 6 months of rapid breast enlargement, erythema, skin ridging, and peau d’orange appearance of the overlying skin, with or without an underlying palpable mass. Because of a lack of consensus on IBC case definition, it has been difficult to definitively determine incidence, identify specific risk factors, and compare studies to evaluate the effectiveness of different therapeutic modalities. In this chapter, we will discuss the clinical characteristics of IBC, methods that have been developed to better define this disease, the controversy surrounding case definition and its associated implication, and the diagnostic criteria established in a consensus statement released by a panel of international experts on IBC.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300
Levine PH, Steinhorn SC, Ries LG, Aron JL (1985) Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) program. J Natl Cancer Inst 74:291–297
Lee BJ, Tannenbaum EN (1924) Inflammatory carcinoma of the breast. Surg Gynecol Obstet 39:580–595
Bozzetti F, Saccozzi R, De Lena M et al (1981) Inflammatory cancer of the breast: analysis of 114 cases. J Surg Oncol 18:355–361
Barker JL, Nelson AJ, Montague ED (1976) Inflammatory carcinoma of the breast. Radiology 121:173–176
Zucali R, Uslenghi C, Kenda R et al (1976) Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer 37:1422–1431
Low J, Berman A, Steinber S et al (2004) Long term follow up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol 22:4065–4074
Ueno NT, Buzdar AU, Singletary SE et al (1997) Combined modality treatment of inflammatory breast carcinoma: twenty years of experience at M.D. Anderson Center. Cancer Chemother Pharmacol 40:321–329
Dawood S, Ueno NT, Valero V et al (2011) Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study. Cancer 117(9):1819–1826
Kim T, Lau J, Erban J (2006) Lack of uniform diagnostic criteria for inflammatory breast cancer limits interpretation of treatment outcomes: a systematic review. Clin Breast Cancer 7:386–395
Edge SB, Byrd DR, Compton CC (eds) (2010) AJCC (American Joint Committee on Cancer) cancer staging manual, 7th edn. Springer, New York
Dawood S, Merajver SD, Viens P et al (2011) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 22(3):515–523
Bell C (1814) A system of operative surgery. Hale & Hosmer, Hartford
Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH (2005–2006) Epidemiology of inflammatory breast cancer (IBC). Breast Dis 22:9–23
Taylor G, Meltzer A (1938) Inflammatory carcinoma of the breast. Am J Cancer 33:33–49
Haagensen CD (1956) Inflammatory carcinoma. Diseases of the breast. W.B. Saunders, Philadelphia, pp 488–498
Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH (2005) Trends in inflammatory breast carcinoma incidence and survival: the surveillance, Epidemiology, and End Results program at the National Cancer Institute. J Natl Cancer Inst 97(13):966–975
Günhan-Bilgen I, Ustün EE, Memiş A (2002) Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology 223(3):829–838
Kushwaha AC, Whitman GJ, Stelling CB, Cristofanilli M, Buzdar AU (2000) Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. AJR Am J Roentgenol 174(2):535–538
Bonnier P, Charpin C, Lejeune C et al (1995) Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition? Int J Cancer 62(4):382–385
Singletary SE, Cristofanilli M (2008) Defining the clinical diagnosis of inflammatory breast cancer. Semin Oncol 35(1):7–10
Lucas FV, Perez-Mesa C (1978) Inflammatory carcinoma of the breast. Cancer 34:382–388
Amparo RS, Angel CD, Ana LH et al (2000) Inflammatory breast carcinoma: pathological or clinical entity? Breast Cancer Res Treat 64:269–273
Denoix P (1970) Treatment of malignant breast cancer. Recent Results Cancer Res 31:92–94
Attia-Sobol J, Ferrière JP, Curé H, Kwiatkowski F et al (1993) Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysis. Eur J Cancer 29(8):1081–1088
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Dawood, S., Valero, V. (2012). Clinical Aspect of Inflammatory Breast Cancer: Diagnosis, Criteria, Controversy. In: Ueno, N., Cristofanilli, M. (eds) Inflammatory Breast Cancer: An Update. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-3907-9_3
Download citation
DOI: https://doi.org/10.1007/978-94-007-3907-9_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-3906-2
Online ISBN: 978-94-007-3907-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)